Silsense TechnologiesS.A.
Manufacture of irradiation, electromedical and electrotherapeutic equipment
Overview
Silsense Technologies is engaged in the IT industry, focusing on the development of innovative technologies based on Polish scientific research. The company has created a scalable telemedicine solution that connects medical specialists with patients and their families, utilizing certified medical devices for monitoring vital parameters. Additionally, Silsense collaborates with academic institutions and research centers to enhance the effectiveness of its projects.
Financials
The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2024.
Results vs industry
News
Industry
Bank accounts
Registered as a VAT taxpayer on 2013-06-26. Active
10 1050 1298 1000 0024 1373 5057- 56 1050 1298 1000 0090 8146 3110
- 59 1050 1298 1000 0024 4179 3268
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
MSiG notices
| Publication date | Event | |
|---|---|---|
| Jan 23, 2024 | Dissolution without liquidation opened |
Public aid
4 public aid cases recorded, with a total value of $801,390.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jul 22, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $122$122 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Jun 16, 2021 | Aid for research and development projects: industrial research | $417.0K$416,958 | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| Jun 16, 2021 | Aid for research and development projects: experimental development | $377.4K$377,435 | Dyrektor Narodowego Centrum Badań i Rozwoju |
Tenders
No recorded participation in tenders.
Authorized Representatives
Manner of representation
Two members of the management board acting jointly.
Supervisory board
Beneficial owners
| Person | Rights | |
|---|---|---|
Joanna Nawrat (47)  | Shareholder of a joint-stock company, 55.0% |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Fastlogicsp. z o.o. | $1,212,148.84 | fastlogic.pl | ||
| Pro-PlusS.A. | $1,116,507.20 | pro-plus.pl | ||
| Noitacsp. z o.o. + limited partnership | $1,156,191.32 | sylop.com | ||
| Mescomp TechnologiesS.A. | $709,799.37 | mescomp.pl | ||
| QvitiS.A. | $588,092.81 | qviti.com | ||
| Inventmedsp. z o.o. | $73,620.90 | inventmed.pl | ||
| ReadiyP.S.A. | $73,178.46 | readiy.com.pl |
FAQ
Last updated: 2026-03-26